Overview

Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This is a study of the efficacy and safety of on-demand dosing of tadalafil or placebo administered for 12 weeks to men with erectile dysfunction caused by spinal cord injury.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
ICOS Corporation
Treatments:
Tadalafil